1Gao fangkun. Advance in senile disease prevention and treatment in China during "Nine Five" phase [J]. Chinese Journal of Clinical Rehabilitation. 2002, 4 (6): 7.
3UK Prospective Diabetes Study Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33 )[J]. Lancet. 1998; 352: 837-853.
二级参考文献6
1李秀钧.胰岛素抵抗综合征（第1版）[M].北京:人民卫生出版社,2002.24-25.
2Alexander CM, Landsman PB, Teutsch SM. NCEP - Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease .Among NHANES Ⅲ Participants Age 50 Years and Older. Diabetes 2003 May;52(5) ;1210- 4.
3Meigs JB, Epidemiology of the insulin resistance syndrome. Curr Diab Rep 2003 Feb;3(1) :73 - 9.
4Sathyaprakash R, Henry RR. Preventing diabetes by treating aspects of the metabolic syndrome. Curt Diab Rep 2002 Oct;2(5) :416- 22.
5Paterson JM, Hollmes MC, Morton NM. Liver - specific over - expression of 11 beta- HSD1 in transgenie mice produces insulin resistance, hyperlipidaemia and fatty liver. Program and abstracts of the 84^th Annual Meeing of The Endocrine Society;June 19 - 22 2002 :San Francisco,Colifonia.Abstracts P2-319.
